Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study on the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

NCT00165763 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00165763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study on the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
Lead sponsor
Eisai Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
Not reported
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

vascular dementia